Twinbeech Capital LP Bio Rad Laboratories, Inc. Transaction History

Twinbeech Capital LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $12 Million - $16.2 Million	44,419 Added 340.48%	57,465 $18.6 Million
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $4.57 Million - $5.51 Million	13,046 New	13,046 $4.68 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $4.8 Million - $6.55 Million	11,629 Added 53.04%	33,555 $14 Million
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $6.2 Million - $7.98 Million	13,365 Added 156.11%	21,926 $10.9 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $3.82 Million - $5.36 Million	7,286 Added 571.45%	8,561 $4.82 Million
Q4 2021 Feb 14, 2022	SELL	$708.84 - $794.68 $1.79 Million - $2 Million	-2,520 Reduced 66.4%	1,275 $963,000
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $2.5 Million - $3.13 Million	3,795 New	3,795 $2.83 Million
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $2.86 Million - $3.22 Million	-4,967 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $2.72 Million - $3.29 Million	4,967 New	4,967 $2.84 Million
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $2.72 Million - $3.21 Million	-5,993 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $2.01 Million - $2.95 Million	5,993 New	5,993 $2.71 Million

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.42B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.